FASN and neoplasm: Due to the important role of lipid metabolism in tumor development, especially the crosstalk between lipid metabolism and TAMs, antitumor drugs targeting lipid metabolism, such as PPAR agonists/antagonists, fatty acid binding protein inhibitors, and fatty acid synthase inhibitors, are currently under development.